Evaluation of the clinical utility of shear wave elastography and dispersion slope measurement in pancreatic cancer

Evaluation of the clinical utility of shear wave elastography and dispersion slope measurement in pancreatic cancer - Shear wave elastgraphy and dispersion in pancreatic cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040173

Enrollment

Registered

2020-04-15

Start date

2019-09-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Pancreatic cancer patients planning to receive chemotherapy 2. Pancreatic cancer patients pathologically diagnosed as adenocarcinoma 3. Patients received sufficient explanations about the study and voluntary gave consent

Exclusion criteria

Exclusion criteria: 1. Patients pathologically diagnosed as carcinomas other than adenocarcinoma 2. Patients who could not detect pancrease with abdominal echo or could not measure share wave imaging because of their figures or other reasons 3. Patients pregnant ,breast feeding patients, or possibly pregnant patients 4. Patients recognized as inappropriate

Design outcomes

Primary

Measure	Time frame
Comparison of shear wave dispersion slope values between pancreatic tumor sites and non-tumor sites before chemotherapy.	—

Secondary

Measure	Time frame
Comparison of shear wave dispersion slope values between pancreatic tumor sites and non-tumor sites before chemotherapy.	—

Countries

Japan

Contacts

Public ContactYunosuke Takishin

Hokkaido University Faculty of Medicine and Graduate School of Medicine Department of Gastroenterology and Hepatology

ofmycloud@live.jp011-716-1161

Outcome results